Astrana Health, Inc. (ASTH)
NASDAQ: ASTH · Real-Time Price · USD
38.76
-0.54 (-1.37%)
May 20, 2026, 4:00 PM EDT - Market closed
Astrana Health Stock Forecast
Stock Price Forecast
According to 11 analysts polled by S&P Global, Astrana Health stock has a consensus rating of "Strong Buy" and an average price target of $44.56. The average 1-year stock price forecast is 14.96% higher than the current stock price, while the lowest is $37 (-4.54%) and the highest is $50 (+29.00%).
Price Target: $44.56 (+14.96%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Astrana Health stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 7 | 7 | 5 | 5 | 5 |
| Buy | 1 | 1 | 1 | 0 | 1 | 1 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 9 | 9 | 6 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Truist Securities | Truist Securities | Strong Buy Maintains $38 → $47 | Strong Buy | Maintains | $38 → $47 | +21.26% | May 14, 2026 |
| TD Cowen | TD Cowen | Strong Buy Maintains $35 → $45 | Strong Buy | Maintains | $35 → $45 | +16.10% | May 12, 2026 |
| Barclays | Barclays | Hold Maintains $26 → $37 | Hold | Maintains | $26 → $37 | -4.54% | May 11, 2026 |
| BTIG | BTIG | Strong Buy Maintains $40 → $50 | Strong Buy | Maintains | $40 → $50 | +29.00% | May 8, 2026 |
| Needham | Needham | Strong Buy Maintains $30 → $41 | Strong Buy | Maintains | $30 → $41 | +5.78% | May 8, 2026 |
Financial Forecast
Revenue This Year
4.06B
from 3.18B
Increased by 27.73%
Revenue Next Year
4.47B
from 4.06B
Increased by 9.94%
EPS This Year
1.26
from 0.46
Increased by 176.03%
EPS Next Year
1.96
from 1.26
Increased by 54.97%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 |
|---|---|---|---|---|---|---|
| High | 4.3B | 4.8B | ||||
| Avg | 4.1B | 4.5B | ||||
| Low | 3.9B | 4.1B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 |
|---|---|---|---|---|---|---|
| High | 35.1% | 18.3% | ||||
| Avg | 27.7% | 9.9% | ||||
| Low | 21.2% | 1.1% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1.65 | 2.57 | |
| Avg | 1.26 | 1.96 | |
| Low | 1.01 | 1.53 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 259.8% | 103.4% | |
| Avg | 176.0% | 55.0% | |
| Low | 120.3% | 21.3% |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.